Intercept Pharmaceuticals Reports Second Quarter 2013 Financial Results

Published: Aug 13, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NEW YORK, Aug. 13, 2013 — /PRNewswire/ -- Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel bile acid therapeutics to treat chronic liver diseases, such as primary biliary cirrhosis, today reported financial results for the quarter and six months ended June 30, 2013 and announced presentations at an upcoming medical conference and upcoming investor conferences. Read more here:

Hey, check out all the research scientist jobs. Post your resume today!

Back to news